Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Maiju Merisalo-Soikkeli"'
Autor:
Siri Tähtinen, Saija Kaikkonen, Maiju Merisalo-Soikkeli, Susanna Grönberg-Vähä-Koskela, Anna Kanerva, Suvi Parviainen, Markus Vähä-Koskela, Akseli Hemminki
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0131242 (2015)
Unfavorable ratios between the number and activation status of effector and suppressor immune cells infiltrating the tumor contribute to resistance of solid tumors to T-cell based therapies. Here, we studied the capacity of FDA and EMA approved recom
Externí odkaz:
https://doaj.org/article/41a59eecd82545118ec1428efba0a1ea
Autor:
Markus Vähä-Koskela, Siri Tähtinen, Susanna Grönberg-Vähä-Koskela, Kristian Taipale, Dipongkor Saha, Maiju Merisalo-Soikkeli, Marko Ahonen, Noora Rouvinen-Lagerström, Mari Hirvinen, Ville Veckman, Sampsa Matikainen, Fang Zhao, Päivi Pakarinen, Jarmo Salo, Anna Kanerva, Vincenzo Cerullo, Akseli Hemminki
Publikováno v:
Molecular Therapy: Oncolytics, Vol 1, Iss C (2014)
Successful cancer control relies on overcoming resistance to cell death and on activation of host antitumor immunity. Oncolytic viruses are particularly attractive in this regard, as they lyse infected tumor cells and trigger robust immune responses
Externí odkaz:
https://doaj.org/article/9b01b1c35c2c4311bda6e7bc3f0a87b4
Autor:
Akseli Hemminki, Markus Vähä-Koskela, Anu J. Airaksinen, Mikko Siurala, Maiju Merisalo-Soikkeli, Dave Lumen, Susanna Grönberg-Vähä-Koskela, Siri Tähtinen
Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82e1d96d46e1a618787354fbc40f247a
https://doi.org/10.1158/2326-6066.22538257.v1
https://doi.org/10.1158/2326-6066.22538257.v1
Autor:
Akseli Hemminki, Markus Vähä-Koskela, Anu J. Airaksinen, Mikko Siurala, Maiju Merisalo-Soikkeli, Dave Lumen, Susanna Grönberg-Vähä-Koskela, Siri Tähtinen
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ed8607e97d23ea5e592d94835515224
https://doi.org/10.1158/2326-6066.22538260
https://doi.org/10.1158/2326-6066.22538260
Autor:
Akseli Hemminki, Markus Vähä-Koskela, Anu J. Airaksinen, Mikko Siurala, Maiju Merisalo-Soikkeli, Dave Lumen, Susanna Grönberg-Vähä-Koskela, Siri Tähtinen
Supplementary Figure S1: Expression levels of intratumoral chemokines following adenovirus injections.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61b2536786fc5108ae7a8ea3d00db71c
https://doi.org/10.1158/2326-6066.22538275.v1
https://doi.org/10.1158/2326-6066.22538275.v1
Autor:
Akseli Hemminki, Markus Vähä-Koskela, Anu J. Airaksinen, Mikko Siurala, Maiju Merisalo-Soikkeli, Dave Lumen, Susanna Grönberg-Vähä-Koskela, Siri Tähtinen
Supplementary Figure S5: Expression of immune checkpoint molecules negatively regulating T-cell function in tumors post-treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b36797c828778a47dd4931baa7fafb97
https://doi.org/10.1158/2326-6066.22538263.v1
https://doi.org/10.1158/2326-6066.22538263.v1
Autor:
Akseli Hemminki, Markus Vähä-Koskela, Anu J. Airaksinen, Mikko Siurala, Maiju Merisalo-Soikkeli, Dave Lumen, Susanna Grönberg-Vähä-Koskela, Siri Tähtinen
Supplementary Figure S2: Treatment schedule and phenotypic characterization of OT-I splenocytes before and after CD8a+ enrichment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::761a8b43016ddd9c9bea5ee1f631b1ab
https://doi.org/10.1158/2326-6066.22538272.v1
https://doi.org/10.1158/2326-6066.22538272.v1
Autor:
Akseli Hemminki, Markus Vähä-Koskela, Anu J. Airaksinen, Mikko Siurala, Maiju Merisalo-Soikkeli, Dave Lumen, Susanna Grönberg-Vähä-Koskela, Siri Tähtinen
Despite the rapid progress in the development of novel adoptive T-cell therapies, the clinical benefits in treatment of established tumors have remained modest. Several immune evasion mechanisms hinder T-cell entry into tumors and their activity with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c5d967271d11b6744787269f5d37e72
https://doi.org/10.1158/2326-6066.c.6548728.v1
https://doi.org/10.1158/2326-6066.c.6548728.v1
Autor:
Akseli Hemminki, Markus Vähä-Koskela, Anu J. Airaksinen, Mikko Siurala, Maiju Merisalo-Soikkeli, Dave Lumen, Susanna Grönberg-Vähä-Koskela, Siri Tähtinen
Supplementary Figure S3: SPECT/CT imaging experiment to study biodistribution and trafficking of radiolabeled OT-I cells in B16.OVA bearing mice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4653792d23a1662176ad1c94f3a75412
https://doi.org/10.1158/2326-6066.22538269.v1
https://doi.org/10.1158/2326-6066.22538269.v1
Autor:
Akseli Hemminki, Markus Vähä-Koskela, Anu J. Airaksinen, Mikko Siurala, Maiju Merisalo-Soikkeli, Dave Lumen, Susanna Grönberg-Vähä-Koskela, Siri Tähtinen
Supplementary Figure S4: Immune cell subsets in the tumors following combination treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae7f9ba401a446cfa749aefc17714a5b
https://doi.org/10.1158/2326-6066.22538266.v1
https://doi.org/10.1158/2326-6066.22538266.v1